Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fleishaker

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
European Journal of Clinical Pharmacology|January 1, 1996
Gender does not affect the degree of induction of tirilazad clearance by phenobarbitalJ C Fleishaker, L K Pearson, G R Peters
Psychopharmacology|January 1, 1991
N-desmethyladinazolam pharmacokinetics and behavioral effects following administration of 10-50 mg oral doses in healthy volunteersJ C Fleishaker, T C Smith, H Friedman, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate following single intravenous infusions of each compound in health volunteersJ C Fleishaker, L K Hulst, T C Smith, et al.
Clinical Pharmacology and Therapeutics|December 1, 1990
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteersJ C Fleishaker, H Friedman, S R Pollock, et al.
Journal of Clinical Psychopharmacology|December 1, 1992
Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteersJ C Fleishaker, L K Hulst, S A Ekernäs, et al.
Pharmaceutical Research|May 1, 1989
Multiple-dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjectsJ C Fleishaker, J P Phillips, T C Smith, et al.
Cephalalgia : an International Journal of Headache|April 12, 2001
Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteersJ C Fleishaker, T A Sisson, B J Carel, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Alprazolam absorption kinetics affects abuse liabilityG K Mumford, S M Evans, J C Fleishaker, et al.
Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of 2.5- to 10-mg oral doses of minoxidil in healthy volunteersJ C Fleishaker, N A Andreadis, I R Welshman, et al.
Clinical Pharmacology and Therapeutics|May 29, 2000
Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteersJ C Fleishaker, T A Sisson, B J Carel, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Pharmacology|January 1, 1996
Gender does not affect the degree of induction of tirilazad clearance by phenobarbitalJ C Fleishaker, L K Pearson, G R Peters
Psychopharmacology|January 1, 1991
N-desmethyladinazolam pharmacokinetics and behavioral effects following administration of 10-50 mg oral doses in healthy volunteersJ C Fleishaker, T C Smith, H Friedman, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate following single intravenous infusions of each compound in health volunteersJ C Fleishaker, L K Hulst, T C Smith, et al.
Clinical Pharmacology and Therapeutics|December 1, 1990
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteersJ C Fleishaker, H Friedman, S R Pollock, et al.
Journal of Clinical Psychopharmacology|December 1, 1992
Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteersJ C Fleishaker, L K Hulst, S A Ekernäs, et al.
Pharmaceutical Research|May 1, 1989
Multiple-dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjectsJ C Fleishaker, J P Phillips, T C Smith, et al.
Cephalalgia : an International Journal of Headache|April 12, 2001
Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteersJ C Fleishaker, T A Sisson, B J Carel, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Alprazolam absorption kinetics affects abuse liabilityG K Mumford, S M Evans, J C Fleishaker, et al.
Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of 2.5- to 10-mg oral doses of minoxidil in healthy volunteersJ C Fleishaker, N A Andreadis, I R Welshman, et al.
Clinical Pharmacology and Therapeutics|May 29, 2000
Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteersJ C Fleishaker, T A Sisson, B J Carel, et al.
Pageof 8